Daniel F. Heitjan

PSA-Net: Deep learning–based physician style–aware segmentation network for postoperative prostate cancer clinical target volumes

Artificial Intelligence in Medicine · 2021-10-19 · 46 citations

Underlying Breast Cancer Risk and Menopausal Hormone Therapy

The Journal of Clinical Endocrinology & Metabolism · 2020-02-13 · 34 citations

The recent Collaborative Group on Hormonal Factors in Breast Cancer (CGHFBC) publication calculated the attributable risk of breast cancer from use of estrogen alone and estrogen plus a synthetic progestogen for less than 5 to 15 or more years of use. This CGHFB report calculated attributable risk based on their findings of relative risk from pooled data from 58 studies. Notably, neither the CGHFBC nor other previous studies have examined the effect of underlying risk of breast cancer on attribu…

Data from Modeling of the Growth Kinetics of Occult Breast Tumors: Role in Interpretation of Studies of Prevention and Menopausal Hormone Therapy

2023-03-31

<div>Abstract<p><b>Background:</b> Autopsy studies report a reservoir of small, occult, undiagnosed breast cancers in up to 15.6% of women dying from unrelated causes. The effective doubling times (EDT) of these occult neoplasms range from 70 to 350 days and mammographic detection threshold diameters from 0.88 to 1.66 cm. Modeling of the biologic behavior of these occult tumors facilitates interpretation of tamoxifen breast cancer prevention and menopausal hormone therapy…

Supplementary Figure 1 from Modeling of the Growth Kinetics of Occult Breast Tumors: Role in Interpretation of Studies of Prevention and Menopausal Hormone Therapy

2023-03-31

<p>PDF file, 33KB, Data from the computer simulated model.</p>

Supplementary Figure Legends from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy

2023-03-31

<p>Legends for the Supplementary Figures</p>